Both Magalhães’ (studied gliomas grade IV) and our study revealed higher levels of soluble HLA-G—we, in the group of all glioma patients (with p-value = 0.048), and Magalhães et al. [62] in gliomas of grade IV—the worst grade of gliomas. This evidence concerns the gene HLA-G and central nervous system cancer.